Sea Pharmaceuticals LLC

Privately held neurotherapeutics company founded in March 2013 by J.P. Pearson and E.J. Martinez and operated in Cambridge Massachusetts USA. Sea Pharmaceuticals LLC conducts research, development, and-commercialization (R-&-D-&-C) of Sea's novel proprietary synthetic small molecules targeting glutamate neurotransmitter system in neurology disorders. Sea is advancing orally administered potential treatments for high need constant bothersome tinnitus (CBT), Epilepsy, and sporadic Amyotrophic Lateral Sclerosis (S-ALS). Sea has 1 emeritus board member EBM & 7 board members. Benjamin F Cravatt PhD is Sea’s emeritus board member. Ben is neurochemist/ biologist Professor Scripps Research Institute and member NAS (USA National Academy Sciences); Ben founded >10 biotech co’s ActivX, Abide / Lundbeck, Vividion /Bayer, et al.; Sea's 7 board members: (i) Eric R Olson PhD molecular biologist, pharmacologist, trustee Cystic Fibrosis Foundation CFF; drug maker led R-&-D-&-C at Vertex VRTX to 4 life-saving CF drugs Kalydeco, Orkambi, Symdeco, Trikafta; former Aurora/ Vertex, Syros, Upjohn, Warner-Lambert/ Parke-Davis; (ii) Mark G Currie PhD molecular pharmacologist; on board IRWD; former CSO, President Ironwood Pharma Inc; Cyclerion Inc, Sepracor, Monsanto; Mark led R-&-D-&-C teams to drugs Celebrex, Bextra, Deramaxx (veterinary), Dynastat (Europe/Asia), Lunesta, Xopenex, Linzess / Constella (EU); (iii) W. Kendall Brown JD Cal-Tech trained physicist; lawyer Brown Associates Des Moines Iowa; computer scientist Advanced Logic Systems; IBM, California, (iv) Michael J Higgins MBA on several boards; was COO CFO Ironwood / Microbia; VP Genzyme, VP Procept); (v) Shaker Sadasivam PhD, MBA engineer formerly CEO Sun Edison Semi -Conductor (SEMI) Monsanto; on boards several co.; (vi) Nabil Elkouh PhD engineer, metals / batteries expert, CEO Conamix; Erigo Tech LLC, American Titanium Works (ATW); (vii) James P Pearson, President & CEO, Sea. See more at https://www.seapharmaceuticals.com